Abstract:Abstract Background and Aims Protein-energy wasting, including muscle atrophy, is one of the most frequently reported problems in patients undergoing hemodialysis. A decline in muscle mass leads to limitation and worsening of physical function and is associated with frailty, disability, and decreased survival. Modified creatinine index was used as a marker of lean body mass. Additionally, a longitudinal study revealed that a decrease in the modified creatinine index over time was independently associated with an increased risk of death in patients undergoing hemodialysis. Moreover, the prevalence of diabetes is high among patients undergoing hemodialysis. Diabetes not only leads to reduced skeletal muscle mass but is also a risk factor for cardiovascular events and death among patients undergoing hemodialysis. The relationship between modified creatinine index and mortality can be altered by the presence of diabetes; however, the effect of diabetes on this relationship among patients undergoing hemodialysis is unclear. This study aimed to examine the association between muscle mass and all-cause mortality in the presence or absence of diabetes, which is highly prevalent in hemodialysis patients. Method We included 361 outpatients undergoing maintenance hemodialysis treatment in 2013–2021 (mean age, 66.3±12.0 years; 61.0% males). Baseline was defined as the date of the first laboratory data and the modified creatinine index measurements, and participants were followed up from baseline to the date of the event (all-cause death, transfer, or end date of study follow-up [May 2021]). Modified creatinine index was calculated using age, sex, predialysis serum creatinine level, and single-pool Kt/V for urea. The primary outcome was death due to any cause. A Cox proportional hazards regression model was used to examine the association between the modified creatinine index and all-cause mortality. The dose–response association between the modified creatinine index and all-cause death was modeled using a restricted cubic spline model. Results A significant interaction was found between the presence of diabetes and modified creatinine index (p = 0.04). In the non-diabetic group, a lower modified creatinine index was associated with a higher risk of all-cause death (hazard ratio [HR], 1.33; 95% confidence interval [95% CI], 1.09–1.63), whereas no significant association between modified creatinine index and all-cause death was observed in the diabetic group (HR, 1.00; 95% CI, 0.83–1.20). Conclusion The modified creatinine index was more strongly associated with all-cause mortality in the nondiabetic group than in the diabetic group. The modified creatinine index is a useful tool for the nondiabetic group, and these results may provide useful information for examining the relationship between skeletal muscle mass and prognosis in patients undergoing hemodialysis.

#2774 ASSOCIATION BETWEEN MODIFIED CREATININE INDEX AND MORTALITY IN PATIENTS UNDERGOING HEMODIALYSIS: A STRATIFIED ANALYSIS IN DIABETES MELLITUS

Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients

Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study

Association between modified simple protein-energy wasting (PEW) score and all-cause mortality in patients receiving maintenance hemodialysis

Impact of Geriatric Nutritional Risk Index and Modified Creatinine Index Combination on Mortality in Hemodialysis Patients

Association of the modified creatinine index with muscle strength and mortality in patients undergoing hemodialysis

Association of the modified creatinine index with quality of life in haemodialysis patients

Ratio of extracellular water to intracellular water and simplified creatinine index as predictors of all-cause mortality for patients receiving hemodialysis

A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study

Nutritional Parameters and Mortality in Incident Hemodialysis Patients

Relationship Between Body Mass Index and Mortality in Hemodialysis Patients: A Meta-Analysis

Intramuscular and abdominal fat measured by computed tomography and mortality of hemodialysis patients

P1493CORRELATION BETWEEN END-DIALYSIS OVER-WEIGHT IN INITIAL STAGE OF HEMODIALYSIS AND PROGNOSIS IN INCIDENT HEMODIALYSIS PATIENTS

Association of changes in body composition with all-cause mortality in patients undergoing hemodialysis: A prospective cohort study

Combined Evaluation of Geriatric Nutritional Risk Index and Modified Creatinine Index for Predicting Mortality in Patients on Hemodialysis

Association of Admission Functional Status and Body Mass Index with Mortality in Patients Receiving Chronic Dialysis: A Nationwide Observational Cohort Study

Impact of Lower Body Mass Index on Risk of All-Cause Mortality and Infection-Related Death in Japanese Chronic Kidney Disease Patients

Modified creatinine index for predicting prognosis in hemodialysis patients: a systematic review and meta-analysis

Association of Diabetes with Cardiovascular Calcification and All-Cause Mortality in Nephropathic Patients on Maintenance Hemodialysis Early: A Retrospective Cohort Study

Association of Lean Body Mass with Nutritional Parameters and Mortality in Hemodialysis Patients: A Long-Term Follow-Up Clinical Study.

Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS